What is the study about? HER2-RADiCAL is investigating whether some people with HER2 positive breast cancer can safely receive less treatment after surgery. HER2 is a protein which can cause cancer to ...
Researchers have taken an important step towards improving the diagnosis and management of prostate cancer by demonstrating that a quantitative imaging technique can accurately assess tumour ...
Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...
Research Data Manager: Integrative Cancer Epidemiology Email: [email protected] Location: Sutton Email: [email protected] Location: Sutton Home Research and discoveries Find a researcher ...
The Covid-19 pandemic has posed many challenges to the cancer research community, but also created opportunities to reimagine the way things are done. While the temporary closures of labs and ...
As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...
A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...
The Institute of Cancer Research, London, works closely with trusts, foundations and charity partners who play an important part in enabling our state-of-the-art research. We recently marked a ...
Image: A scanning electron microscope image of a prostate cancer cell. Credit: Anne Weston, Francis Crick Institute. CC BY-NC 4.0. At The Institute of Cancer Research, London, we often refer to ...
A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports. Almost half of the patients in the trial that could be evaluated saw their tumour shrink after ...
Scientists have identified a more accurate way of predicting which patients with multiple myeloma, a type of blood cancer, are likely to relapse early following treatment. A study carried out by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results